
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
Cartilage injuries can turn simple movement into a challenge. Without timely treatment, damage may progress and increase the risk of arthritis or future joint replacement.
At Liquid Cartilage, our goal is joint preservation and regeneration—not replacement. With ChondroFiller®, we deliver advanced, evidence-led care on Harley Street.

Cartilage provides the smooth, low-friction surface that lets your joints move comfortably. It doesn’t readily self-repair, but with the right scaffold and biological cues, regeneration is possible.
Act early to preserve more of what you have.

ChondroFiller® is an acellular, biologic collagen scaffold delivered in liquid form. Once placed, it gels within minutes, filling the defect and providing a framework that invites your cells to rebuild cartilage.
Think of it like “epoxy” for cartilage—without the plastic.
One treatment. One step. A chance to keep your joint for the long term.


ChondroFiller® sits in a different class— structural regenerative implant.
| Treatment | Analogy | What it Does | Limitation |
|---|---|---|---|
| HA (Hyaluronic Acid) | WD-40 | Improves lubrication for short-term comfort | Temporary; does not regenerate tissue |
| Arthrosamid® | Silicone | Acts on the synovium to reduce pain signalling | Not regenerative; literature notes complication rates up to 30% |
| ChondroFiller® | Epoxy resin | Fills defects, stabilises, and promotes true cartilage repair | Most robust injectable option for structural repair |
ChondroFiller®: our structural, regenerative approach to focal cartilage defects.
Small joints: thumb, fingers, elbow, AC joint, toes, TMJ…
From £2,100
Large joints: knee, hip, shoulder, ankle
From £2,800
Best for knee, hip, shoulder
From £6,500 (knee), £9,500 (hip/shoulder)
Our proprietary MSC Co-Delivery Technique
Introductory offer: your consultation fee is credited toward treatment if you proceed.

Quick, no-obligation chat

Comprehensive assessment with Prof. Paul Lee

Injection, Keyhole, or Liquid Cartilage™

Precise and minimally invasive



Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)
Everything you want to know about ChondroFiller® at Liquid Cartilage.
ChondroFiller® is an acellular collagen gel that fills cartilage defects and forms a scaffold for your own cells to regenerate healthy tissue. Unlike temporary injections, it supports hyaline-like restoration for smoother motion and protection long-term.
HA or Arthrosamid® may give short-term pain relief, while ChondroFiller® aims to rebuild cartilage. Compared with replacement, it preserves your natural joint and avoids prosthesis risks. Our approach is regenerate-first.
Studies show +30 IKDC in knees, +33 Harris Hip Score in hips, and improved ankle metrics. MRI (MOCART) typically reads 70–87. Globally, >19,000 cases support safety and function.
Best for focal defects up to 6 cm² in knees, hips, ankles, or small joints. Active younger patients often benefit, but older patients may qualify if surrounding cartilage is stable.
Delivered via precise injection or keyhole surgery. The gel sets in minutes. Expect partial weight-bearing ~6 weeks, steady return to cycling/swimming, and most sports around ~12 months alongside specialist rehab.
Harley Street location; UK ICRS Centre of Excellence. Led by Prof. Paul Lee, with advanced options like Liquid Cartilage™ (ChondroFiller® + cells) to prioritise preservation.
Discover what makes ChondroFiller® unique at Liquid Cartilage.

Intra-articular ankle fractures deliver two separate insults to cartilage: acute impact damage at injury, then chronic wear from residual misalignment after bone repair. Cartilage injury occurs in over 70% of ankle fractures yet remains invisible on standard radiographs, meaning this progressive damage is routinely missed at initial fracture assessment.

ChondroFiller injection delivers a collagen scaffold into the damaged elbow joint, which gels within minutes and attracts the patient's own progenitor cells to regenerate cartilage tissue without requiring surgery or general anaesthetic.

ChondroFiller injection places an acellular collagen scaffold directly onto cartilage defects under real-time ultrasound guidance. The scaffold polymerises immediately in the joint fluid, then over six to twelve months recruits the patient's own cells to progressively remodel the damage into cartilage-like tissue.

Cartilage damage in FAI shifts the condition from a friction problem to a structural deficit because years of grinding from misshapen bones accumulate into macroscopic cartilage loss, irreversible by conservative treatment and narrowing the window for joint-preserving options.

The 6 cm² ceiling for ChondroFiller injection reflects the collagen scaffold's capacity to retain position and recruit progenitor cells for cartilage repair — a biological constraint, not administrative rule.

ChondroFiller deposits a collagen scaffold that self-gels within minutes; over six weeks, progenitor cells migrate into it and rebuild cartilage, with most patients returning to sport by month twelve.